Cantabio Pharmaceuticals Overview
- Founded
-
2009
- Status
-
Public
- Employees
-
11
- Stock Symbol
-
CTBO
- Investments
-
1
- Share Price
-
$1.01
- (As of Thursday Closing)
Cantabio Pharmaceuticals General Information
Description
Cantabio Pharmaceuticals Inc is the United States based preclinical stage biotechnology company. It is focused on commercializing novel therapies and the intellectual property generated from its research and development activities for Parkinson's disease and Alzheimer's disease and other related diseases. In addition, In addition, it is also engaged in the development of therapeutic proteins that can pass through the blood-brain barrier and supplement in vivo levels of proteins which display loss of function during disease conditions.
Contact Information
Website
www.cantabio.com
Formerly Known As
Gardedam Therapeutics
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Stock Exchange
PINX
Primary Office
- 2225 East Bayshore Road
- Palo Alto, CA 94303
- United States
Cantabio Pharmaceuticals Stock Performance
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.01 | $25.00 | $1.01 - $1.01 | 200.00 |
Cantabio Pharmaceuticals Financials Summary
|
In Thousands, USD |
TTM 31-Dec-2018 | FY 2018 31-Mar-2018 | FY 2017 31-Mar-2017 | FY 2016 31-Mar-2016 |
|---|---|---|---|---|
| EV | 2,316 | 3,324 | 4,189 | 53,509 |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (331) | (1,392) | (1,072) | (751) |
| Net Income | (1,543) | (2,012) | (1,112) | (751) |
| Total Assets | 326 | 109 | 34 | 52 |
| Total Debt | 1,409 | 1,205 | 369 | 0 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Cantabio Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Cantabio Pharmaceuticals Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Cantabio Pharmaceuticals Inc is the United States based preclinical stage biotechnology company. It is focused on commer
Biotechnology
Palo Alto, CA
11
As of 2022
000000000000
000000
iscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim ven
0000 000000000
South San Francisco, CA
000
As of 0000
00000
000000 - 000
00000
00000
henderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cup
0000 000000000
Grand Rapids, MI
0
As of 0000
0000
0000
0000-00-00
000000&0
0000
Add Comparison
Cantabio Pharmaceuticals Competitors (29)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Alector | Formerly VC-backed | South San Francisco, CA | 000 | 00000 | 000000 - 000 | 00000 |
| 00000 000000000000 | Formerly VC-backed | Grand Rapids, MI | 0 | 0000 | 000000&0 | 0000 |
| 0000000 | Venture Capital-Backed | Framingham, MA | 00 | 000.00 | 00000000000 | 000.00 |
| 000000000 | Formerly VC-backed | Gaithersburg, MD | 00 | 00000 | 00000000 | 00000 |
| 000000000 | Formerly VC-backed | South San Francisco, CA | 00 | 00000 | 000000000 | 00000 |
Cantabio Pharmaceuticals Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Gergely Tóth Ph.D | Founder & Chief Executive Officer | ||
| Simon Peace | Chief Accounting Officer, Accounting | ||
| Thomas Roger Sawyer Ph.D | Chief Operating Officer |
Cantabio Pharmaceuticals Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Cantabio Pharmaceuticals Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Cantabio Pharmaceuticals Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000 00000000 | 18-Dec-2015 | 0000000000 | Consulting Services (B2B) | 0000000 0 |